CI&T heads into its third-quarter report with a split personality. Demand has rarely looked better, with record revenue, a pipeline growing faster than at any point in the past year and a pricing model that is finally lifting gross margin. Yet the stock has slid since management cut its full-year profitability outlook to fund a sales push. The November 11 release, due after the close, will help show which of those stories deserves more weight.
The Street expects earnings of $0.08 a share on revenue of $146.6 million, implying growth of roughly 14% on the bottom line and 15% on the top line from a year earlier. That revenue figure sits just above management's own third-quarter target of $145.7 million, or about 14.4% growth, so analysts are asking for a modest beat rather than a blowout. That bar looks reachable for a company that has delivered seven straight quarters of double-digit organic growth and raised its full-year revenue range twice, most recently to $566 million to $578 million. The catch is that consensus implies a step down from the 21.9% organic pace of the second quarter. Some of that reflects tougher comparisons, but a revenue print that merely matches guidance would hint that the acceleration story is cooling.
The more consequential number is adjusted EBITDA margin. Management lowered its 2026 target to 15% to 17% from 17% to 19%, attributing the cut to sales spending that jumped toward 12% of revenue and to a stronger Brazilian real. With first-half margins averaging a bit above 14%, even the low end of the new range requires the second half to run near 16%, and the midpoint implies something closer to 18%. That is a meaningful rebound from the second quarter's 13.3%. The third quarter needs to show visible progress toward that level, along with signs that sales investment is drifting back toward the roughly 10% of revenue management described as the structural run rate. A margin that stalls in the low teens would make the reduced guidance look less like a floor and more like a ceiling.
On the growth side, the evidence that matters is whether AI monetization keeps compounding. Value-based pricing reached 40% of new engagements in the first half, double the share flagged a quarter earlier, and that mix shift pushed adjusted gross margin up to 32.4% from 30.6%. Holding or extending that gross margin gain would validate the idea that CI&T is selling outcomes rather than hours. Investors should also look for early traction from the Anthropic Claude partnership, the Mistral tie-up and the new agentic reinvention offering, all introduced last quarter. Regionally, North America slowed to about 10% growth, which management blamed on renewal timing. A rebound there would support that explanation, while continued weakness alongside a still-shrinking consumer goods vertical would raise questions about breadth beyond financial services and telecom.
The market has not given management much benefit of the doubt. Shares are down nearly 10% since the last report, lagging the S&P 500 by almost 7 points, and at $3.08 they sit well below the 200-day moving average of $3.95 and toward the lower end of the post-earnings range between $2.80 and $3.94. Sentiment has softened its bearish tilt, moving to 6.4% bearish from 15.7% heading into the prior report, suggesting skepticism is easing even as the share price has not followed.
That combination of improving fundamentals and a discounted stock sets up a clear test. If CI&T can pair another revenue beat with a credible margin recovery path, the investment-year narrative holds and the selloff looks overdone. If margins fail to climb, the market will likely conclude that growth is being bought rather than earned.